Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

A prospective comparison of dynamic contrast-enhanced MRI and 51Cr-EDTA clearance for glomerular filtration rate measurement in 42 kidney transplant recipients.

Taton B, De La Faille R, Asselineau J, Perez P, Merville P, Colin T, Combe C, Sourbron S, Grenier N.

Eur J Radiol. 2019 Aug;117:209-215. doi: 10.1016/j.ejrad.2019.02.002. Epub 2019 Feb 4.

PMID:
31221527
2.

Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.

Kaminski H, Jarque M, Halfon M, Taton B, Di Ascia L, Pfirmann P, Visentin J, Garrigue I, Déchanet-Merville J, Moreau JF, Crespo E, Montero N, Melilli E, Meneghini M, Pascual M, Couzi L, Manuel O, Bestard O, Merville P.

J Infect Dis. 2019 Apr 26. pii: jiz194. doi: 10.1093/infdis/jiz194. [Epub ahead of print]

PMID:
31157865
3.

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Pizzolato G, Kaminski H, Tosolini M, Franchini DM, Pont F, Martins F, Valle C, Labourdette D, Cadot S, Quillet-Mary A, Poupot M, Laurent C, Ysebaert L, Meraviglia S, Dieli F, Merville P, Milpied P, Déchanet-Merville J, Fournié JJ.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11906-11915. doi: 10.1073/pnas.1818488116. Epub 2019 May 22.

PMID:
31118283
4.

Late vs early-onset CMV infections in kidney transplantation, still a topical issue, reply to Ono et al.

Kaminski H, Couzi L, Merville P.

Transpl Infect Dis. 2019 May 11:e13103. doi: 10.1111/tid.13103. [Epub ahead of print] No abstract available.

PMID:
31077514
5.

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.

Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, Kamar N, Merville P, Junge M, Thaiss F, Nashan B; Athena Study Group.

Kidney Int. 2019 Jul;96(1):231-244. doi: 10.1016/j.kint.2019.01.041. Epub 2019 Feb 27.

PMID:
31027892
6.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
7.

Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2019 Apr;568(7752):E6. doi: 10.1038/s41586-019-1109-3.

PMID:
30944482
8.

C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection.

Goutaudier V, Perrochia H, Mucha S, Bonnet M, Delmas S, Garo F, Garrigue V, Lepreux S, Pernin V, Serre JE, Szwarc I, Merville P, Ramounau-Pigot A, René C, Visentin J, Morgan BP, Frémeaux-Bacchi V, Mourad G, Couzi L, Le Quintrec M.

Front Immunol. 2019 Mar 8;10:235. doi: 10.3389/fimmu.2019.00235. eCollection 2019.

9.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
10.

Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Jacquemont L, Hourmant M, Del Bello A, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Maillard N, Dubourg L, Lemoine S, Garrouste C, Pottel H, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2019 Apr;95(4):896-904. doi: 10.1016/j.kint.2018.11.029. Epub 2019 Feb 26.

PMID:
30819555
11.

The age-calibrated measured glomerular filtration rate improves living kidney donation selection process.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Del Bello A, Girerd S, Kessler M, Flamant M, Vidal-Petiot E, Peraldi MN, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Caillard S, Gatault P, Büchler M, Maillard N, Dubourg L, Roquet O, Garrouste C, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2018 Sep;94(3):616-624. doi: 10.1016/j.kint.2018.05.016.

PMID:
30143068
12.

Two cases of tacrolimus-induced neutropenia: A probably under-diagnosed cause of neutropenia after solid-organ transplantation.

Clément J, Taton B, Merville P, Viallard JF, Lazaro E, Couzi L, Rivière E.

Clin Transplant. 2018 Jul;32(7):e13295. doi: 10.1111/ctr.13295. Epub 2018 Jun 15. No abstract available.

PMID:
29907985
13.

Overcoming non-specific binding to measure the active concentration and kinetics of serum anti-HLA antibodies by surface plasmon resonance.

Visentin J, Couzi L, Dromer C, Neau-Cransac M, Guidicelli G, Veniard V, Coniat KN, Merville P, Di Primo C, Taupin JL.

Biosens Bioelectron. 2018 Oct 15;117:191-200. doi: 10.1016/j.bios.2018.06.013. Epub 2018 Jun 7.

PMID:
29902635
14.

Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13. Erratum in: Nature. 2019 Apr;568(7752):E6.

PMID:
29899452
15.

The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.

Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy182. No abstract available.

PMID:
29897514
16.

Impact of the individualized risks of end-stage renal disease on living kidney donor selection.

Nguyen QL, Merville P, Couzi L.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2245-2252. doi: 10.1093/ndt/gfy145.

PMID:
29846692
17.

A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.

Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C.

Am J Transplant. 2018 Dec;18(12):2945-2954. doi: 10.1111/ajt.14925. Epub 2018 Jun 20.

PMID:
29745007
18.

The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.

Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1853-1863. doi: 10.1093/ndt/gfy088. Erratum in: Nephrol Dial Transplant. 2018 Oct 1;33(10):1872.

PMID:
29672702
19.

Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays.

Guidicelli G, Visentin J, Franchini N, Borg C, Merville P, Couzi L, Taupin JL.

HLA. 2018 Jun;91(6):507-513. doi: 10.1111/tan.13263.

PMID:
29604172
20.

Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database.

Prezelin-Reydit M, Combe C, Harambat J, Jacquelinet C, Merville P, Couzi L, Leffondré K.

Nephrol Dial Transplant. 2019 Mar 1;34(3):538-545. doi: 10.1093/ndt/gfy039.

PMID:
29579221
21.

Intravenous Immunoglobulins in the Prevention of Rejection of a Second or Third Kidney Graft.

Glotz D, Rostaing L, Merville P, Squifflet JP, Lebranchu Y.

Transplant Proc. 2018 Jan - Feb;50(1):70-71. doi: 10.1016/j.transproceed.2017.11.010.

PMID:
29407334
22.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B; French PTLD Registry.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1663-1670. doi: 10.2215/CJN.03790417. Epub 2017 Aug 17.

23.

Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.

Thilly N, Chanliau J, Frimat L, Combe C, Merville P, Chauveau P, Bataille P, Azar R, Laplaud D, Noël C, Kessler M.

BMC Nephrol. 2017 Apr 5;18(1):126. doi: 10.1186/s12882-017-0529-2.

24.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study.

Bertrand D, Dehay J, Ott J, Sberro R, Brunelle C, Kamar N, Colosio C, Chatelet V, Albano L, Girerd S, Audard V, Barbet C, Dantal J, Ducloux D, Durrbach A, Garrigue V, Hazzan M, Heng AE, Mariat C, Merville P, Rerolle JP, Moulin B, Guerrot D.

Transpl Int. 2017 Mar;30(3):256-265. doi: 10.1111/tri.12923.

25.

Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

Mourad G, Glyda M, Albano L, Viklický O, Merville P, Tydén G, Mourad M, Lõhmus A, Witzke O, Christiaans MHL, Brown MW, Undre N, Kazeem G, Kuypers DRJ; Advagraf-based immunosuppression regimen examining new onset diabetes mellitus in kidney transplant recipients (ADVANCE) study investigators.

Transplantation. 2017 Aug;101(8):1924-1934. doi: 10.1097/TP.0000000000001453.

26.

Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.

Visentin J, Bachelet T, Borg C, Franchini N, Nong T, Lee JH, Couzi L, Merville P, Guidicelli G, Taupin JL.

Transplantation. 2017 Mar;101(3):624-630. doi: 10.1097/TP.0000000000001239.

PMID:
27336398
27.

Genome-Wide Association Study of Acute Renal Graft Rejection.

Ghisdal L, Baron C, Lebranchu Y, Viklický O, Konarikova A, Naesens M, Kuypers D, Dinic M, Alamartine E, Touchard G, Antoine T, Essig M, Rerolle JP, Merville P, Taupin JL, Le Meur Y, Grall-Jezequel A, Glowacki F, Noël C, Legendre C, Anglicheau D, Broeders N, Coppieters W, Docampo E, Georges M, Ajarchouh Z, Massart A, Racapé J, Abramowicz D, Abramowicz M.

Am J Transplant. 2017 Jan;17(1):201-209. doi: 10.1111/ajt.13912. Epub 2016 Jul 22.

28.

Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.

Garrigue I, Moulinas R, Recordon-Pinson P, Delacour ML, Essig M, Kaminski H, Rerolle JP, Merville P, Fleury H, Alain S.

J Clin Virol. 2016 Jul;80:74-81. doi: 10.1016/j.jcv.2016.04.017. Epub 2016 Apr 27.

PMID:
27214758
29.

Radiologic imaging of the renal parenchyma structure and function.

Grenier N, Merville P, Combe C.

Nat Rev Nephrol. 2016 Jun;12(6):348-59. doi: 10.1038/nrneph.2016.44. Epub 2016 Apr 12. Review.

PMID:
27067530
30.

Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.

Kaminski H, Couzi L, Garrigue I, Moreau JF, Déchanet-Merville J, Merville P.

Am J Transplant. 2016 Aug;16(8):2384-94. doi: 10.1111/ajt.13781. Epub 2016 Apr 8. Erratum in: Am J Transplant. 2017 Feb;17 (2):588-589.

31.

Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays.

Visentin J, Guidicelli G, Couzi L, Merville P, Lee JH, Di Primo C, Taupin JL.

Hum Immunol. 2016 Nov;77(11):1048-1054. doi: 10.1016/j.humimm.2016.02.008. Epub 2016 Feb 20.

PMID:
26902993
32.

Prevalence of IgA Antibodies to β2-Glycoprotein I: A Population-Dependent Feature?

Visentin J, Ramaharo D, Ryman A, Contin-Bordes C, Merville P.

Transplantation. 2016 Mar;100(3):e13-4. doi: 10.1097/TP.0000000000001062. No abstract available.

PMID:
26900811
33.

A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation.

Pouché L, Koitka M, Stojanova J, Woillard JB, Monchaud C, Villeneuve C, Essig M, Abraham J, Le Meur Y, Rerolle JP, Kamar N, Rostaing L, Merville P, Gandia P, Bouchet S, Petersen BS, Marquet P, Picard N.

Pharmacogenomics. 2016 Mar;17(4):375-91. doi: 10.2217/pgs.15.181. Epub 2016 Feb 19.

PMID:
26894651
34.

Cytomegalovirus-Induced γδ T Cells During Rejection: An Ambivalent T Cell.

Bachelet T, Merville P, Dechanet-Merville J, Couzi L.

Am J Transplant. 2016 Jan;16(1):368-9. doi: 10.1111/ajt.13568. No abstract available.

35.

Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow….

Bachelet T, Visentin J, Guidicelli G, Merville P, Couzi L, Taupin JL.

Transpl Int. 2016 Apr;29(4):508-10. doi: 10.1111/tri.12745. Epub 2016 Feb 17. No abstract available.

36.

Evolution and Determinants of Health-Related Quality-of-Life in Kidney Transplant Patients Over the First 3 Years After Transplantation.

Villeneuve C, Laroche ML, Essig M, Merville P, Kamar N, Coubret A, Lacroix I, Bouchet S, Fruit D, Marquet P, Rousseau A; EPIGREN study group.

Transplantation. 2016 Mar;100(3):640-7. doi: 10.1097/TP.0000000000000846.

PMID:
26569063
37.

Calcineurin Inhibitors Downregulate HNF-1β and May Affect the Outcome of HNF1B Patients After Renal Transplantation.

Faguer S, Esposito L, Casemayou A, Pirson Y, Decramer S, Cartery C, Hazzan M, Garrigue V, Roussey G, Cointault O, Ho T, Merville P, Devuyst O, Gourdy P, Chassaing N, Bascands JL, Kamar N, Schanstra JP, Rostaing L, Chauveau D.

Transplantation. 2016 Sep;100(9):1970-8. doi: 10.1097/TP.0000000000000993.

38.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y.

Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958.

PMID:
26555944
39.

Quelle valeur accorder à l'IMC dans l'évaluation de la morbidité périopératoire de la transplantation rénale ?

Queruel V, Kabore R, Guillaume A, Moreau K, Leffondre K, Couzi L, Quinart A, Rogier J, Tauzin-Fin P, Merville P, Robert G, Pasticier G, Bensadoun H, Ferrière J, Bernhard J.

Prog Urol. 2015 Nov;25(13):764-5. doi: 10.1016/j.purol.2015.08.101. French. No abstract available.

PMID:
26544295
40.

Evaluation of the iBeads assay as a tool for identifying class I HLA antibodies.

Visentin J, Guidicelli G, Nong T, Moreau JF, Merville P, Couzi L, Lee JH, Taupin JL.

Hum Immunol. 2015 Sep;76(9):651-6. doi: 10.1016/j.humimm.2015.09.012. Epub 2015 Sep 25.

PMID:
26407911
41.

CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.

Thibault G, Paintaud G, Legendre C, Merville P, Coulon M, Chasseuil E, Ternant D, Rostaing L, Durrbach A, Di Giambattista F, Büchler M, Lebranchu Y.

Transpl Int. 2016 Feb;29(2):184-95. doi: 10.1111/tri.12688. Epub 2015 Oct 8.

42.

Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.

Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P.

Transplantation. 2016 Jan;100(1):159-66. doi: 10.1097/TP.0000000000000821.

PMID:
26262501
43.

[Immunomonitoring for cytomegalovirus infection in kidney transplantation: Development and prospects].

Kaminski H, Couzi L, Déchanet-Merville J, Merville P.

Nephrol Ther. 2015 Nov;11(6):465-73. doi: 10.1016/j.nephro.2015.03.005. Epub 2015 Jul 21. Review. French.

PMID:
26206770
44.

OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, Maurouard T, Dougall D, Davizon ES, Dumortier H, Douchet I, Raffray L, Richez C, Lazaro E, Duffau P, Truchetet ME, Khoryati L, Mercié P, Couzi L, Merville P, Schaeverbeke T, Viallard JF, Pellegrin JL, Moreau JF, Muller S, Zurawski S, Coffman RL, Pascual V, Ueno H, Blanco P.

Immunity. 2015 Jun 16;42(6):1159-70. doi: 10.1016/j.immuni.2015.05.012. Epub 2015 Jun 9.

45.

Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants.

Kaminski H, Garrigue I, Couzi L, Taton B, Bachelet T, Moreau JF, Déchanet-Merville J, Thiébaut R, Merville P.

J Am Soc Nephrol. 2016 Feb;27(2):637-45. doi: 10.1681/ASN.2014100985. Epub 2015 Jun 8.

46.

Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome.

Viot B, Garrigue I, Taton B, Bachelet T, Moreau JF, Dechanet-Merville J, Merville P, Couzi L.

Transpl Infect Dis. 2015 Aug;17(4):497-509. doi: 10.1111/tid.12408. Epub 2015 Jul 7.

PMID:
26052675
47.

Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.

Guidicelli G, Guerville F, Lepreux S, Wiebe C, Thaunat O, Dubois V, Visentin J, Bachelet T, Morelon E, Nickerson P, Merville P, Taupin JL, Couzi L.

J Am Soc Nephrol. 2016 Feb;27(2):615-25. doi: 10.1681/ASN.2014040326. Epub 2015 Jun 5.

48.

Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience.

Petitpierre F, Cornelis F, Couzi L, Lasserre AS, Tricaud E, Le Bras Y, Merville P, Combe C, Ferriere JM, Grenier N.

Eur Radiol. 2015 Nov;25(11):3263-71. doi: 10.1007/s00330-015-3730-3. Epub 2015 May 17.

PMID:
25981217
49.

Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.

Rostaing L, Hertig A, Albano L, Anglicheau D, Durrbach A, Vuiblet V, Moulin B, Merville P, Hazzan M, Lang P, Touchard G, Hurault deLigny B, Quéré S, Di Giambattista F, Dubois YC, Rondeau E; CERTITEM Study Group.

Am J Transplant. 2015 May;15(5):1303-12. doi: 10.1111/ajt.13132. Epub 2015 Mar 23.

50.

Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study.

Bachelet T, Nodimar C, Taupin JL, Lepreux S, Moreau K, Morel D, Guidicelli G, Couzi L, Merville P.

Clin Transplant. 2015 May;29(5):439-46. doi: 10.1111/ctr.12535. Epub 2015 Mar 30.

PMID:
25739833

Supplemental Content

Loading ...
Support Center